港股異動 | 華潤醫療(1515.HK)漲逾4% 獲多家機構看好

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

港股異動 | 華潤醫療(1515.HK)漲逾4% 獲多家機構看好

格隆匯 12-28 15:40

格隆匯12月28日丨華潤醫療(1515.HK)股價高位震盪，現報4.75港元，漲幅4.17%，總市值61.6億港元。廣發證券指，預計公司利潤增速好於上半年，料2021-23年歸母淨利潤為4.49/5.13/5.8億元，PE為11/9.6/8.5倍，維持買入評級，目標價8.55港元。招商證券(香港)認為，國家醫保局近期發佈了《國家醫療保障局關於印發DRG/DIP支付方式改革三年行動計劃的通知》，華潤醫療等股將從DRG/DIP改革較大程度獲益，予買入評級，目標價11.7港元。

华润医疗(01515.HK)

Relevant Stocks

华润医疗(01515.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

港股異動 | 華潤醫療(1515.HK)漲逾4% 獲多家機構看好

Services

About Us

Agreement Statement